OKYO Pharma Limited, (OKYO): Price and Financial Metrics

OKYO Pharma Limited, (OKYO): $1.07

0.04 (+3.88%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

F

Add OKYO to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#256 of 338

in industry

OKYO Price/Volume Stats

Current price $1.07 52-week high $2.12
Prev. close $1.03 52-week low $0.81
Day low $1.02 Volume 55,400
Day high $1.10 Avg. volume 125,136
50-day MA $1.06 Dividend yield N/A
200-day MA $1.27 Market Cap 36.20M

OKYO Stock Price Chart Interactive Chart >


OKYO Pharma Limited, (OKYO) Company Bio


OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. It is developing OK-101 for the treatment of dry eye disease; and OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. The company is also developing chemerin and chemerin analogues to treat the cytokine release syndrome associated with COVID-19 infections and other conditions, such as acute respiratory distress syndrome. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.


OKYO Latest News Stream


Event/Time News Detail
Loading, please wait...

OKYO Latest Social Stream


Loading social stream, please wait...

View Full OKYO Social Stream

OKYO Price Returns

1-mo 3.88%
3-mo 2.88%
6-mo -18.94%
1-year -37.06%
3-year N/A
5-year N/A
YTD -39.55%
2023 -7.33%
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!